Each 1 syringe (2.0 mL) contains: YYD-302: 4:1 w/w mixed hydrogel of sodium hyaluronate gel crosslinked by divinyl sulfone and sodium hyaluronate fluid 2.04 g (as Sodium hyaluronate 40 mg).
The product is a sterile, clear colorless viscoelastic gel supplied in a syringe.
The syringe is packed in a blister with one sterile needle. The gel contains mixture of sodium hyaluronate hydrogel cross-linked by divinyl sulfone and sodium hyaluronate fluid.
Hyaluronic acid is a naturally occurring polysaccharide that exists in many connective tissues such as joint fluid and serves to provide viscoelasticity of joint synovial fluid.
Trauma and degenerative joint diseases reduce hyaluronic acid in the joints and cannot absorb or disperse impacts, resulting in joint damage, which is a source of pain. Intraarticular administration of sodium hyaluronate can replace (substitute) synovial fluid as viscoelastic supplement.
Ingredients: Sodium hyaluronate, Divinyl sulfone, Potassium dihydrogen phosphate, Disodium monohydrogen phosphate dodecahydrate, Potassium chloride, Sodium chloride, Water for injection.
Other Services
Country
Account